1
James Aggen, John H Griffin, Mathai Mammen, Daniel Marquess, Edmund J Moran, David Oare: Muscarinic receptor antagonists. Theravance, Jeffrey A Hagenah, Joyce G Cohen, February 17, 2004: US06693202 (123 worldwide citation)

Disclosed are multibinding compounds which are muscarinic receptor antagonists. The multibinding compounds of this invention containing from 2 to 10 ligands covalently attached to one or more linkers. Each ligand is, independently of each other, a muscarinic receptor antagonist or an allosteric modu ...


2
Daniel Marquess, Martin S Linsell, S Derek Turner, Sean G Trapp, Daniel D Long, Paul R Fatheree: Cross-linked glycopeptide-cephalosporin antibiotics. Theravance, Jeffrey A Hagenah, April 12, 2005: US06878686 (24 worldwide citation)

This invention provides cross-linked glycopeptide-cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using suc ...


3
Paul R Fatheree, Martin S Linsell, Daniel Marquess, Sean G Trapp, Edmund J Moran, James B Aggen: Cross-linked glycopeptide-cephalosporin antibiotics. Theravance, Jeffrey A Hagenah, June 27, 2006: US07067482 (23 worldwide citation)

This invention provides cross-linked glycopeptide—cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using suc ...


4
Paul R Fatheree, Martin S Linsell, Daniel D Long, Daniel Marquess, Edmund J Moran, Matthew B Nodwell, S Derek Turner, James Aggen: Cross-linked glycopeptide-cephalosporin antibiotics. Theravance, Jeffrey A Hagenah, December 13, 2005: US06974797 (22 worldwide citation)

This invention provides cross-linked glycopeptide—cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using suc ...


5
Paul R Fatheree, Martin S Linsell, Daniel Marquess, Daniel D Long, Jason P Chinn, Matthew B Nodwell, Edmund J Moran, James B Aggen: Cross-linked glycopeptide-cephalosporin antibiotics. Theravance, Jeffrey A Hagenah, June 27, 2006: US07067481 (21 worldwide citation)

This invention provides cross-linked glycopeptide—cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using suc ...


6
Paul R Fatheree, Martin S Linsell, Daniel Marquess, Sean G Trapp, Edmund J Moran, James B Aggen: Cross-linked glycopeptide-cephalosporin antibiotics. Theravance, Jeffrey A Hagenah, October 9, 2007: US07279458 (21 worldwide citation)

This invention provides cross-linked glycopeptide—cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using suc ...


7
Daniel Marquess, Paul R Fatheree, S Derek Turner, Daniel D Long, Seok Ki Choi, Adam A Goldblum, Daniel Genov: Quinolinone-carboxamide compounds as 5-HT4 receptor agonists. Theravance, Jeffrey A Hagenah, Roberta P Saxon, May 20, 2008: US07375114 (20 worldwide citation)

The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful ...


8
Daniel Marquess, Martin S Linsell, S Derek Turner, Sean G Trapp, Daniel D Long, Paul R Fatheree: Cross-linked glycopeptide-cephalosporin antibiotics. Theravance, Jeffrey A Hagenah, February 7, 2006: US06995138 (18 worldwide citation)

This invention provides cross-linked glycopeptide-cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using suc ...


9
Seok Ki Choi, Paul Fatheree, Roland Gendron, Adam A Goldblum, Lan Jiang, Daniel D Long, Daniel Marquess: Quinolinone-carboxamide compounds. Theravance, Jeffrey A Hagenah, Roberta P Saxon, July 8, 2008: US07396933 (17 worldwide citation)

The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful ...


10
Seok Ki Choi, Paul Fatheree, Adam A Goldblum, Lan Jiang, Daniel D Long, Daniel Marquess, S Derek Turner: receptor agonist compounds, 5-HT. Theravance, Jeffrey A Hagenah, Roberta P Saxon, July 15, 2008: US07399862 (16 worldwide citation)

The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful ...



Click the thumbnails below to visualize the patent trend.